We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-18.45%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$2.12B
AUM Growth
+$287M
Cap. Flow
+$729M
Cap. Flow %
34.43%
Top 10 Hldgs %
10.68%
Holding
2,455
New
598
Increased
849
Reduced
552
Closed
442

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$70.1M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$17M
3
CNC icon
Centene
CNC
+$11.6M
4
NVDA icon
NVIDIA
NVDA
+$11.5M
5
ADNT icon
Adient
ADNT
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 16.77%
2 Financials 12.38%
3 Healthcare 11.71%
4 Industrials 11.7%
5 Consumer Discretionary 10.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HXL icon
2001
Hexcel
HXL
$7.76B
$4K ﹤0.01%
63
-48,618
-100% -$2.93M
CHMA
2002
DELISTED
Chiasma, Inc. Common Stock
CHMA
$4K ﹤0.01%
1,202
-1,898
-61% -$6.81K
CLD
2003
DELISTED
Cloud Peak Energy Inc
CLD
$4K ﹤0.01%
+9,761
New +$13.9K
RRR icon
2004
Red Rock Resorts
RRR
$3.61B
$3K ﹤0.01%
162
-43,889
-100% -$1.03M
VRCA icon
2005
Verrica Pharmaceuticals
VRCA
$85M
$3K ﹤0.01%
43
-148
-77% -$18K
SYRS
2006
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3K ﹤0.01%
53
-137
-72% -$10.4K
PRVB
2007
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$3K ﹤0.01%
+1,450
New +$4.17K
AGTC
2008
DELISTED
Applied Genetic Technologies Corporation
AGTC
$3K ﹤0.01%
+1,115
New +$6.53K
XELA
2009
DELISTED
Exela Technologies, Inc. Common Stock
XELA
0
UROV
2010
DELISTED
Urovant Sciences Ltd.
UROV
$3K ﹤0.01%
+447
New +$4.07K
PIR
2011
DELISTED
Pier 1 Imports, Inc.
PIR
$2K ﹤0.01%
+377
New +$10.3K
QTNT
2012
DELISTED
Quotient Limited Ordinary Shares
QTNT
$1K ﹤0.01%
+2
New +$524
AMR
2013
DELISTED
Alta Mesa Resources Inc
AMR
$1K ﹤0.01%
900
-7,715
-90% -$19.5K
AAPL icon
2014
CALL
Apple
AAPL
$4.57T
-22,400
Closed -$1.26M
AAPL icon
2015
PUT
Apple
AAPL
$4.57T
-31,200
Closed -$1.76M
AAT
2016
American Assets Trust
AAT
$1.4B
-6,993
Closed -$261K
ABG icon
2017
Asbury Automotive
ABG
$3.84B
-5,812
Closed -$400K
ABM icon
2018
ABM Industries
ABM
$2.86B
-7,546
Closed -$243K
ABT icon
2019
Abbott
ABT
$186B
-6,951
Closed -$510K
ACGL icon
2020
Arch Capital
ACGL
$33.8B
-28,020
Closed -$835K
AFMD
2021
DELISTED
Affimed
AFMD
-3,281
Closed -$143K
AGEN
2022
Agenus
AGEN
$295M
-1,121
Closed -$47K
AGNC icon
2023
AGNC Investment
AGNC
$12.9B
-12,700
Closed -$237K
AGX icon
2024
Argan
AGX
$8.35B
-5,199
Closed -$224K
AHT
2025
Ashford Hospitality Trust
AHT
$21M
-6
Closed -$36K

Similar funds

Cubist Systematic Strategies's Q4 2018 Portfolio in Review

As of Q4 2018, Cubist Systematic Strategies held 2,455 positions worth $2.12B, up 16% from $1.83B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Cubist Systematic Strategies deployed $729M of net new capital in Q4 2018, opening 598 new positions and adding to 849 existing holdings. Its largest new stake was Walgreens Boots Alliance: 113,965 shares worth $7.79M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was NXP Semiconductors, an estimated $15.4M trimmed.

  • Cubist Systematic Strategies's largest Q4 2018 buy was Walgreens Boots Alliance: 113,965 shares worth $7.79M.
  • Cubist Systematic Strategies added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $70.1M increase.
  • Cubist Systematic Strategies's biggest Q4 2018 reduction was NXP Semiconductors, cutting an estimated $15.4M.
  • Cubist Systematic Strategies fully exited Wellcare Health Plans, Inc. in Q4 2018, selling an estimated $10M.
  • Cubist Systematic Strategies's ten largest holdings make up 11% of its $2.12B portfolio in Q4 2018.
  • Cubist Systematic Strategies opened 598 new positions and closed 442 in Q4 2018.
  • Cubist Systematic Strategies's portfolio value rose 16% quarter-over-quarter to $2.12B.

Based on Cubist Systematic Strategies's 13F filing for Q4 2018, filed 14 Feb 2019.